Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacek Bil

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Statins and Cancer: A Complex Relationship Worth ExploringJacek Bil
Journal of Personalized Medicine|August 26, 2022
Individualized Management of Patients with Coronary Artery DiseaseJacek Bil
International Journal of Cardiology|May 20, 2019
Does the daily risk assessment of adverse outcomes after percutaneous coronary interventions facilitate the personalized medicine approach?Jacek Bil
Life (Basel, Switzerland)|June 26, 2026
Beyond the Diagnosis-Personalized Risk Stratification in Contemporary Cardiovascular MedicineJacek Bil
BMC Cardiovascular Disorders|July 7, 2021
The vicious cycle: a history of obesity and COVID-19Jacek Bil, Olga Możeńska
Journal of Thoracic Disease|September 14, 2016
Bioresorbable vascular scaffolds-what does the future bring?Jacek Bil, Robert J Gil
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|October 20, 2025
Guidelines and procedures for renal denervation in Western European hospitals: how does renal denervation fit the Polish context?Jacek Bil, Robert J Gil
Future Oncology (London, England)|May 4, 2018
Statins use and cancer: an updateMartyna Zaleska, Olga Mozenska, Jacek Bil
Kardiologia Polska|January 26, 2021
Sclerostin and cardiovascular disease: any prognostic implications? Authors' replyAdam Kern, Tomasz Stompor, Jacek Bil
Interventional Cardiology (London, England)|March 29, 2018
Dedicated Bifurcation Drug-eluting Stent BiOSS® - A Novel Device for Coronary Bifurcation TreatmentRobert J Gil, Dobrin Vassilev, Jacek Bil
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Statins and Cancer: A Complex Relationship Worth ExploringJacek Bil
Journal of Personalized Medicine|August 26, 2022
Individualized Management of Patients with Coronary Artery DiseaseJacek Bil
International Journal of Cardiology|May 20, 2019
Does the daily risk assessment of adverse outcomes after percutaneous coronary interventions facilitate the personalized medicine approach?Jacek Bil
Life (Basel, Switzerland)|June 26, 2026
Beyond the Diagnosis-Personalized Risk Stratification in Contemporary Cardiovascular MedicineJacek Bil
BMC Cardiovascular Disorders|July 7, 2021
The vicious cycle: a history of obesity and COVID-19Jacek Bil, Olga Możeńska
Journal of Thoracic Disease|September 14, 2016
Bioresorbable vascular scaffolds-what does the future bring?Jacek Bil, Robert J Gil
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|October 20, 2025
Guidelines and procedures for renal denervation in Western European hospitals: how does renal denervation fit the Polish context?Jacek Bil, Robert J Gil
Future Oncology (London, England)|May 4, 2018
Statins use and cancer: an updateMartyna Zaleska, Olga Mozenska, Jacek Bil
Kardiologia Polska|January 26, 2021
Sclerostin and cardiovascular disease: any prognostic implications? Authors' replyAdam Kern, Tomasz Stompor, Jacek Bil
Interventional Cardiology (London, England)|March 29, 2018
Dedicated Bifurcation Drug-eluting Stent BiOSS® - A Novel Device for Coronary Bifurcation TreatmentRobert J Gil, Dobrin Vassilev, Jacek Bil
Pageof 13